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Purpose: To investigate the underlying genetic variation between candidate genes and primary angle closure glaucoma
(PACG) in both Nepalese and Australian populations.
Methods: A total of 213 patients with PACG (106 Nepalese and 107 Australian) and 492 age and sex matched controls
(204 Nepalese and 288 Australian) were included in the current study. Three candidate genes were selected; methyl-
tetrahydrofolate reductase (MTHFR), calcitonin receptor-like receptor gene (CALCRL), and membrane frizzled-related
protein (MFRP). Tag single nucleotide polymorphisms (SNPs) were selected and genotyped to capture the majority of
common variation across each locus. Allele and haplotype analyses were conducted using PLINK.
Results: SNPs in the nanophthalmos gene MFRP were found to be nominally associated with PACG under the allelic
model. Two SNPs were associated in the Australian cohort (rs948414; p=0.02 and rs36015759; p=0.02), and a single SNP
in the Nepalese cohort (rs10790289; p=0.03), however these SNPs failed to remain significant after adjustment for sex
and age. A haplotype at the CALCRL gene (AATACAGAT) was associated in the Australian cohort (corrected p-
value=0.024). No association was observed in either cohort for MTHFR.
Conclusions: This study implicates genetic variation at the CALCRL gene in the pathogenesis of PACG in an Australian
Caucasian cohort. Additionally, the MFRP gene shows tendency to be associated with PACG in both the Australian and
Nepalese cohorts. Further investigation in a larger cohort is warranted to confirm these findings. No statistically significant
associations were identified between MTHFR and PACG in either population.
Glaucoma is characterized by progressive destruction of
the optic nerve, with associated loss of peripheral vision [1].
It is classified by the anatomy and the appearance of the
iridocorneal angle in the anterior chamber into open-angle or
angle-closure glaucoma. Primary open angle glaucoma
(POAG) is the most common form of glaucoma worldwide
[2]. However, primary angle closure glaucoma (PACG) is
believed to be the most common cause of bilateral glaucoma
blindness worldwide [3].
PACG is a subtype of glaucoma, and is defined as an
anatomic disorder of the anterior chamber, in which the
drainage angle is occluded by the anterior apposition of the
iris [4]. In Addition to shallow anterior chamber and narrow
angles, PACG is also characterized by change in lens
thickness and position [5], shorter axial length [6], and
hyperopic refractive error (farsightedness) [7]. The disease is
correlated with older age, female gender and race (anterior
chamber angle is shallower in Eskimos and Asians) [8].
An epidemiological study of PACG has explored the
difference in the ocular biometric parameters between
Chinese and Caucasian patients. There was no significant
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variation in the anterior chamber depth and the axial length.
However, it was found that hyperopia is higher in Caucasian
cases, while the radius of corneal curvature is smaller in Asian
cases, which makes the anterior chamber angle more crowded,
which could explain the higher prevalence of PACG among
the Asian population [9].
Pathogenesis of PACG is complex and depends on
multiple factors including anatomy, physiology and/or
environmental effects. It is difficult to predict which eyes with
shallow anterior chamber will develop glaucomatous features.
Wang and colleagues [10] revealed that approximately one in
ten Chinese individuals with narrow angles developed PACG.
Family history is another strong risk factor which suggests a
firm genetic predisposition to this disease. Siblings of Chinese
individuals with ACG have up to a 50% probability of having
narrow angles [11], another study reported that first degree
relatives of individuals with PACG patients have a 6–9 fold
increased risk of developing this disease [10].
Several studies have investigated the association of
candidate genes with PACG, such as methyl-tetrahydrofolate
reductase (MTHFR) [12,13], membrane frizzled-related
protein (MFRP) [14,15], and the calcitonin receptor-like
receptor gene (CALCRL) [16]. MTHFR encodes the
methylenetetrahydrofolate reductase (MTHFR) enzyme,
which is responsible for the conversion of homocysteine to
methionine [17]. C677T and A1298C polymorphisms were
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found to be associated with a reduction in MTHFR enzyme
activity [18], which leads to an increase in serum
homocysteine levels [19]. High homocysteine levels may
predispose to neuronal cell death [20], and extracellular
matrix (ECM) remodelling [21]. ECM remodelling is
suggested to be an important factor in the development of a
short axial length [22], one of the biometric features of PACG.
A study conducted on Caucasian patients with open angle
glaucoma reported an association between MTHFR gene
variants and elevation of plasma homocysteine level [23].
Michael et al. [12,13], identified two non-synonymous single
nucleotide polymorphisms (SNPs) associated with PACG in
the Pakistani population C677T (rs1801133) and A1298C
(rs1801131).
Mutations in MFRP are known to cause autosomal
recessive nanophthalmos, characterized by short axial length,
a high degree of hyperopia, increased lens/eye volume ratio,
and small corneal diameter [24]. Patients often develop severe
angle closure glaucoma due to the crowding of the anterior
chamber. Thus, this gene has been studied in relation to
PACG, but no association has been detected to date [14,15].
Cao et al. [16] identified an association between
CALCRL polymorphisms rs1157699 and PACG in Chinese
individuals. Overexpression of this gene causes pupillary
sphincter muscle relaxation, closure of the anterior chamber
angle with obstruction of the aqueous outflow and elevation
of the intraocular pressure (IOP) [25].
The purpose of this present study is to investigate the
association of these candidate genes with PACG in both
Australian Caucasians and Nepalese cohorts.
METHODS
Participants were recruited from Ophthalmology clinics in
both Australia and Nepal. Ethical approval was obtained from
the human research ethics committees of the Southern
Adelaide Health Service/Flinders University and Nepal
Glaucoma Eye Clinic, Tilganga Institute of Ophthalmology,
Kathmandu Nepal, and the study was conducted in accordance
with the Declaration of Helsinki and its subsequent revisions.
Informed consent was obtained from each individual. The
Australian cohort is of self-reported Caucasian ethnicity.
In total, 213 participants with PACG (107 Australian and
106 Nepalese) were recruited; acute attack of PACG has been
reported in 35 cases of the Australian cohort, and 53 cases of
the Nepalese one.
Every participant received a complete eye examination
including slit lamp examination of the anterior chamber,
central corneal thickness, visual acuity, measurement of the
intraocular pressure (IOP), fundus examination with special
attention to optic cup health and size, and visual field
assessment. The diagnosis of PACG was based on the
presence of 1) glaucomatous optic neuropathy with cup: disc
ratio ≥0.7; 2) peripheral visual loss; 3) presence of at least 180
degrees of closed angle in which the trabecular meshwork is
not visible on gonioscopy; and 4) elevated IOP greater than
21 mmHg. Patients with previous cataract extraction and
secondary angle closure glaucoma due to causes such as
uveitis, trauma or lens subluxation were excluded.
The control group consisted of a total of 492 (288
Australian and 204 Nepalese) individuals The Australian
cohort was ascertained from aged residential care facilities in
Adelaide, South Australia. Nepalese controls were
participants in a population based study in Kathmandu, Nepal.
Individuals were chosen specifically to be matched for age,
gender and ethnic group to the Nepalese cases. Both control
groups were examined and required to have intraocular
pressure less than 21 mmHg, normal optic nerve heads with
cup:disc ratio of <0.5, and no family history of glaucoma or
previous glaucoma surgery.
Genomic DNA was extracted from peripheral whole
blood using the QiaAmp Blood Midi (Nepalese samples) or
Maxi (Australian samples) Kit (Qiagen, Valencia, CA). Tag
SNPs for each candidate gene were selected using the tagger
program implemented in Haploview 4.2 using CEU: CEPH
(Utah residents with ancestry from northern and western
Europe) for the Australian cohort and Han Chinese in Beijing,
China (CHB) samples for the Nepalese cohort. Tag SNPS
were chosen using pairwise tagging, to have an r2>0.8 with
SNPs displaying a minor allele frequency of 5% in the
population. SNPs previously reported to be associated with
PACG were included in the selection of tags. All tag SNPs
were typed in both cohorts.
Genotyping was conducted using the iPLEX Gold
chemistry (Sequenom Inc., San Diego, CA) on an Autoflex
mass spectrometer (Sequenom Inc.) at the Australia Genome
Research Facility (AGRF), Brisbane. All analyses were
conducted using PLINK [26].
SNPs were assessed for compliance with Hardy–
Weinberg equilibrium using the χ2 test. Genetic association
was assessed under an allelic model. Bonferroni correction
was applied to each p-value according to the number of SNPs
typed from that gene. Haplotype analyses from our data were
conducted in PLINK based on the observed linkage
disequilibrium blocks, as visualized in Haploview [27] using
the “solid spine” definition. Multivariate analysis was
conducted using logistic regression in PLINK.
Power calculations were conducted using the Genetic
Power Calculator [28]. Assuming complete linkage between
the disease-causing variant and marker, as well as a
prevalence of PACG in the Caucasian population of 0.27%
[29], our Australian subset has 90.6% power to detect a
significant genetic association for PACG at the α=0.05 level
for a genotypic relative risk of 1.6, and a risk allele frequency
of 0.4 under an additive model. The prevalence of PACG in
the Nepalese population (4.3%) was extrapolated using data
from China [10]. In our Nepalese cohort, under an additive
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model we have 95.1% power to detect a genetic variant with
similar effect size and allele frequency as that outlined for our
Australian cohort.
RESULTS
In total, 705 individuals (310 Nepalese and 395 Australians)
were enrolled in this study. Table 1 displays characteristics
and clinical data of cases and controls for each cohort. Age
and gender differences between cases and controls were
evident in the Australian cohort (p<0.01) but not the Nepalese
(p=0.85). Similarly, spherical equivalent was not statistically
significantly different between Nepalese cases and controls
(p=0.16), while Australian cases were more hyperopic than
controls (p<0.001). No SNP deviated from Hardy–Weinberg
equilibrium in either cohort (p>0.05).
The allelic association p-values of all typed SNPs are
presented in Table 2. Of the total 30 tag SNPs, three SNPs
from the MFRP gene were nominally associated with PACG;
rs948414 T allele, with odds ratio (OR) of 0.7 (95%CI: 0.5–
0.9, p=0.02), and rs36015759 A allele, with an OR of 0.6
(95%CI: 0.4–0.9, p=0.02) in the Australian Caucasian
population. In the Nepalese cohort, SNP rs10790289 T allele,
was associated with OR of 1.4 (95% CI: 1.0–1.9, p=0.03),
however none of them showed association when the results
were adjusted for sex and age (p-values of 0.18, 0.07, 0.06
respectively). No other SNPs in this in this study showed
significant association in either cohort.
Haplotypes were assessed in blocks of linkage
disequilibrium for each gene. The global p-value for
association at the CALCRL gene was suggestive, but not
significant (p=0.06). However, one of the six haplotypes in
the CALCRL gene (AATACAGAT) was significantly
associated with PACG in the Australian cohort (OR: 0.11,
95%CI: 0.02–0.77, p=0.004). The association remained
significant following Bonferroni correction for the six
observed haplotypes (corrected p=0.024; Table 3). This
haplotype was more frequent in controls than cases (4% versus
1%, respectively). The remaining genes did not show any
significant haplotype association in either cohort (data not
shown).
DISCUSSION
Glaucoma is well known to have a genetic basis. Positive
family history is considered an important risk factor for
developing the disease [30]. Green et al. [31], found that 60%
of primary open angle glaucoma (POAG) patients in
Tasmania have a family history of POAG. The main genetic
factors involved in the development of glaucoma are still
unclear, and the majority of glaucoma-causing genes
identified to date are for POAG [32,33]. Relatively few
candidate genes have been studied for association with PACG.
We chose three that were previously studied for association
with PACG to attempt to replicate the findings in two separate
populations.
We genotyped previously identified SNPs; C677T
(rs1801133) and A1298C (rs1801131), in MTHFR with other
tag SNPs to cover the majority of common genetic variation
within these genes in both Nepalese and Caucasian
populations. The C677T polymorphism (rs1801133) in the
MTHFR gene affects the homocysteine concentration, and an
increase in its plasma levels has been detected in Caucasian
patients with PACG. Elevated homocysteine levels lead to
scleral restructuring, and structural remodelling of connective
tissue of the anterior segment and trabecular meshwork [12].
Ethnic differences seem to play a role in the reported
associations of this polymorphism with various types of
glaucoma. A relationship between MTHFR C677T
polymorphism and open angle glaucoma in Caucasians [34]
and normal tension glaucoma in Koreans [35] has been
reported. However, this variant was not associated with
normal tension glaucoma or POAG in either Japanese [36], or
Central European populations [37]. Recently Michael et al.
[12,13] found a significant association between the TT and
AC genotypes of MTHFR C677T (rs1801133) and A1298C
(rs1801131) polymorphisms with PACG in a Pakistani cohort.
Our data did not support association of variants in the
MTHFR gene with PACG in either the Australian or Nepalese
cohorts. This gene has been studied in a variety of glaucoma
phenotypes and ethnic groups with limited overlap of each
between studies. The variable results may reflect these study
and phenotype differences, or could suggest that the gene has
a very limited role to play in PACG.
Mutations in the Membrane-type frizzled protein
(MFRP) gene cause autosomal recessive nanophthalmos,
which is characterized by short axial length, a high degree of
hyperopia, a high lens/eye volume ratio, and a small corneal
diameter [24]. The protein is expressed mainly in the retinal
pigment epithelium and the ciliary body [38] and plays a role
TABLE 1. CHARACTERISTICS OF THE NEPALESE AND AUSTRALIAN COHORTS.
 Australian Nepalese
Variables Case Control p-value Case Control p-value
Number 107 288 - 106 204 -
Sex (% female) 67% 53% 0.01 76% 75% 0.85
Mean age in years (SD) 76 (8.2) 69(11.2) <0.001 57.3 (12.30) 60.3 (13.71) 0.07
Mean SE in diopters (SD) 0.95 (2.15) 0.125 (0.37) <0.001 −0.30 (1.64) 0.10 (0.31) 0.16
          Abbreviations: SD, standard deviation; SE, spherical equivalent.
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in ocular development, regulating the ocular axial growth.
Homozygous MFRP mutation carriers have a shorter axial
length than normal eyes, with an increase in both choroidal
and scleral thickness, which in turn leads to axial hyperopia
[39]. As both nanophthalmos and PACG have similar
anatomic abnormalities, MFRP was considered to be a
candidate gene for PACG. However, studies in the Chinese
and Taiwanese patients did not show any significant
association [14,15]. However, the current finding of nominal
significance after adjustment for age and sex in the Caucasian
population represents the first time this gene has been studied
for association with PACG in Caucasians, and although the
finding doesn’t survive multiple testing correction and thus
may represent a false positive finding, further investigation
with larger cohorts is warranted.
Association between SNP rs1157699 in the calcitonin
receptor-like receptor (CALCRL) and acute PACG had been
identified by Cao et al. [16]. CALCRL is a G protein-coupled
receptor transported to the cell membrane from the
endoplasmic reticulum by receptor activity modifying protein
2 (RAMP2) where it is glycosylated and becomes a receptor
for adrenomedulin (ADM) [40]. ADM mRNA was found to be
expressed in the irido-ciliary body where it has a relaxant
effect on iris sphincter which leads to obstruction of the
aqueous humor outflow and elevation of the IOP [25]. In
addition, exogenous ADM has a strong effect on IOP through
specific ADM receptors, implying that ADM is a candidate
for an endogenous IOP modulator [41]. In our study,
rs1157699 was not typed for technical reasons, but SNPs
rs2063505 and rs6706141 which are in strong linkage
disequilibrium with rs1157699 did not demonstrate any
association in either cohort. However, the AATACAGAT
haplotype of SNPs in the CALCRL gene did show an
association in the Australian cohort (corrected p-
value=0.024), which suggests genetic variation at the
CALCRL gene may play a role in PACG. The examination of
haplotypes in candidate gene studies can be superior to
investigating individual SNPs when the haplotype tags
variation not tagged by the individual SNPs [42]. This
haplotype appears to be protective in the Australian cohort as
the frequency is higher in controls 4% than in cases 1%.
However, it is still a relatively rare haplotype and the
implication of its association is not yet clear. This result
requires replication in an independent cohort for further
validation. No associations were found in the Nepalese cohort;
however, this may reflect ethnic differences in disease
pathogenesis. Alternatively, the associated haplotype is more
common in Nepal and the lack of association here may suggest
that the Australian cohort result is a false positive finding.
Further work is required to assess the potential involvement
of this gene with PACG and replication of these results in an
independent Caucasian cohort is required to confirm the
findings of this study.
A limitation of this study was the use of HapMap Han
Chinese in Beijing, China (CHB) sample for the selection of
tag SNPs for the Nepalese cohort. This population was the
most closely related population available at the time of the
study. As allele frequencies and linkage disequilibrium
structure were similar between the two data sets for these
SNPs, we consider the choice of tag SNPs appropriate. The
power of this study may also be limiting and we cannot rule
out single SNP effects in these genes smaller than the
detection limit of this study.
In conclusion, association of a rare haplotype at the
CALCRL gene with PACG in the Australian cohort may
implicate this gene further in the pathogenesis of PACG,
although further investigation is required to confirm it.
Polymorphic sequence variation at the nanophthalmos gene,
MFRP showed a trend toward association but requires a larger
cohort to definitively detect an effect in this complex disease.
Positive associations previously reported at MTHFR gene
failed to replicate in our study in both Caucasian and Nepalese
populations.
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